Search results
Results from the WOW.Com Content Network
Primum non nocere (Classical Latin: [ˈpriːmũː noːn nɔˈkeːrɛ]) is a Latin phrase that means "first, do no harm". The phrase is sometimes recorded as primum nil nocere . [ 1 ] [ better source needed ]
It is often said that "First do no harm" (Latin: Primum non nocere) is a part of the original Hippocratic oath. A related phrase is found in Epidemics, Book I, of the Hippocratic school: "Practice two things in your dealings with disease: either help or do not harm the patient". [7]
The concept of non-maleficence is embodied by the phrase, "first, do no harm," or the Latin, primum non nocere. Many consider that should be the main or primary consideration (hence primum): that it is more important not to harm your patient, than to do them good, which is part of the Hippocratic oath that doctors take. [46]
one should remove evil or harm; one should practice good; Ordinary moral discourse and most philosophical systems state that a prohibition on doing harm to others as in #1 is more compelling than any duty to benefit others as in #2–4. This makes the concept of "first do no harm" different from the other aspects of beneficence. [2]
Most people enter military service “with the fundamental sense that they are good people and that they are doing this for good purposes, on the side of freedom and country and God,” said Dr. Wayne Jonas, a military physician for 24 years and president and CEO of the Samueli Institute, a non-profit health research organization.
The overall market for AI in healthcare is expected to grow to $188 billion by 2030 from $11 billion in 2021, according to Precedence Research.The market for clinical software alone is expected to ...
A famous maxim (Epidemics I.11) advises: "As to diseases, make a habit of two things—to help, or at least to do no harm." [44] The most famous work in the Hippocratic Corpus is the Hippocratic Oath, a landmark declaration of medical ethics.
WASHINGTON (Reuters) - U.S. manufacturers are optimistic that the sector will emerge from a prolonged recession next year, though capital expenditure growth was likely to fall short of 2024's pace.